GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Enterprise Value

Quest PharmaTech (TSXV:QPT) Enterprise Value : C$4.51 Mil (As of Jun. 10, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Quest PharmaTech's Enterprise Value is C$4.51 Mil. Quest PharmaTech's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was C$-3.00 Mil. Therefore, Quest PharmaTech's EV-to-EBIT ratio for today is -1.51.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Quest PharmaTech's Enterprise Value is C$4.51 Mil. Quest PharmaTech's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was C$-3.00 Mil. Therefore, Quest PharmaTech's EV-to-EBITDA ratio for today is -1.51.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Quest PharmaTech's Enterprise Value is C$4.51 Mil. Quest PharmaTech's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.00 Mil. Therefore, Quest PharmaTech's EV-to-Revenue ratio for today is .


Quest PharmaTech Enterprise Value Historical Data

The historical data trend for Quest PharmaTech's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Enterprise Value Chart

Quest PharmaTech Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.42 32.91 15.39 12.46 4.51

Quest PharmaTech Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.46 13.39 13.58 11.90 4.51

Competitive Comparison of Quest PharmaTech's Enterprise Value

For the Biotechnology subindustry, Quest PharmaTech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest PharmaTech's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's Enterprise Value falls into.



Quest PharmaTech Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Quest PharmaTech's Enterprise Value for the fiscal year that ended in Jan. 2024 is calculated as

Quest PharmaTech's Enterprise Value for the quarter that ended in Jan. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quest PharmaTech  (TSXV:QPT) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Quest PharmaTech's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4.511/-2.997
=-1.51

Quest PharmaTech's current Enterprise Value is C$4.51 Mil.
Quest PharmaTech's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-3.00 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Quest PharmaTech's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=4.511/-2.995
=-1.51

Quest PharmaTech's current Enterprise Value is C$4.51 Mil.
Quest PharmaTech's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-3.00 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Quest PharmaTech's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4.511/0
=

Quest PharmaTech's current Enterprise Value is C$4.51 Mil.
Quest PharmaTech's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quest PharmaTech Enterprise Value Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest PharmaTech (TSXV:QPT) Business Description

Traded in Other Exchanges
N/A
Address
8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Executives
Ragupathy Madiyalakan Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines